News and Trends 8 Mar 2023
Women in STEM: challenges and opportunities
In this article to celebrate International Women's Day, we asked women in STEM for their comments on the challenges they…
News and Trends
- Latest Posts
News and Trends 8 Mar 2023
How to encourage more women in life science jobs
In this article to celebrate International Women's Day, we asked six women biotech professionals for their observations on women in…
News and Trends 8 Mar 2023
The challenges of tackling dementia in women
Dr Andrea Pfeifer, chief executive officer of AC Immune SA, talks to Labiotech about dementia research, and how dementia affects…
News and Trends 3 Mar 2023
Beyond Biotech podcast 36: Bio-Europe Spring and Cellular Origins
Two of the interviews on the podcast today are related to Bio-Europe Spring. There are conversations with Rosie Bernard, senior…
ADVERTISEMENT
News and Trends 3 Mar 2023
Lilly to develop Confo pain drug
Confo Therapeutics, which works on the discovery of medicines targeting G-protein coupled receptors (GPCRs), has announced a worldwide licensing agreement…
News and Trends 3 Mar 2023
Porton and DanausGT look to boost development of gene and cell therapy
Porton Advanced Solutions Ltd. and DanausGT Biotechnology Co., Ltd. have announced a strategic collaboration in gene and cell therapy pipelines…
News and Trends 3 Mar 2023
Debiopharm adds to oncology pipeline
Debiopharm, an independent Swiss-based, biopharmaceutical company, has obtained the global rights for FT-3171, a small molecule USP1 inhibitor program targeting…
News and Trends 3 Mar 2023
Orphan drug designation for Laevoroc metabolic immune checkpoint inhibitor
Laevoroc Immunology, a privately-owned, Swiss oncology development company, has announced that the U.S. Food and Drug Administration (FDA) has granted…
News and Trends 2 Mar 2023
Antiverse identifies therapeutic antibodies targeting GPCRs
Antiverse Ltd has announced the successful identification of functional antibody clusters targeting two G-protein-coupled receptors (GPCRs), both displaying versatile binding…
News and Trends 2 Mar 2023
Partnership formed to develop miRNA to treat pancreatic cancer
RNA delivery and therapeutics company SiSaf Ltd is to collaborate with the University of Leipzig in Germany to develop targeted…
ADVERTISEMENT
News and Trends 2 Mar 2023
Genomic medicine company Chroma raises $135M
Chroma Medicine, Inc., a genomic medicine company advancing single-dose epigenetic editing therapeutics, has completed a $135 million Series B financing.…
News and Trends 2 Mar 2023
Ten new companies join BioInnovation Institute’s Venture Lab program
BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating life science research, has added 10 new companies to its…
News and Trends 2 Mar 2023
New lipid nanoparticle CRISPR delivery system developed
Lipid nanoparticles have been used to encapsulate CRISPR-Cas9 and deliver it to cells in mice, where it was highly effective…
News and Trends 28 Feb 2023
What’s happening on Rare Disease Day?
Rare Disease Day 2023 is on February 28. The day is dedicated to raising awareness for the approximately 300 million…
News and Trends 28 Feb 2023
European Commission approves first gene therapy for hemophilia B
The European Commission has approved the first gene therapy for the treatment of hemophilia B developed by biotech company CSL…
News and Trends 28 Feb 2023
Peter MacCallum Cancer Centre and Cartherics to work on CAR-T cell therapy for ovarian cancer
Peter MacCallum Cancer Centre (Peter Mac) in Australia and Cartherics Pty Ltd have entered into a collaborative development program agreement…
ADVERTISEMENT
News and Trends 28 Feb 2023
GC Biopharma acquiring hemophilia rare disease pipeline
GC Biopharma Corp., a South Korean provider of biopharmaceutical products, has signed an asset purchase agreement with Catalyst Biosciences to…
News and Trends 24 Feb 2023
Resalis Therapeutics receives €10M to develop obesity and NAFLD treatment
Resalis Therapeutics has completed a seed financing round of €10 million to establish a non-coding RNA (ncRNA)-based therapeutic approach for…
News and Trends 24 Feb 2023
Beyond Biotech podcast 35: Rare Disease Day
As February 28 is Rare Disease Day, we have three guests on the podcast today all relevant to rare diseases.…
News and Trends 24 Feb 2023
AELIX announces ‘important step towards HIV eradication’
AELIX Therapeutics S.L., a clinical-stage biotechnology company specializing in the discovery and development of immunotherapies for HIV infection, has announced…